Image

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)

Recruiting
50-90 years
Both
Phase N/A
  • Simplified (AI rewritten)
  • Technical (Original)

The Hope Study is researching if sensory stimulation can help people with mild to moderate Alzheimer's disease (AD) feel better. Alzheimer's is a disease that affects the brain and memory. This study will last up to 12 months and needs 530 people aged 50-90. Participants will be split into two groups: one gets real treatment, the other gets a sham (fake) treatment. Double-blind means neither the participants nor the researchers know who is getting the real treatment. Participants will visit clinical sites up to 6 times over the year. Some might be asked to do a special test called a lumbar puncture to study cerebrospinal fluid (CSF), the liquid around the brain and spine. People with certain health issues, like seizures or some heart diseases, won't be able to join the study. If you're interested, you can learn more at Hope Study for AD.

  • Study duration: 12 months, with visits every 3 months.
  • Participants receive either real or sham sensory treatment daily.
  • Some may undergo a lumbar puncture to check brain fluid.
Print
Study details
    Alzheimer Disease
    Alzheimer Disease 1
    Alzheimer Disease 2
    Alzheimer Disease 3
    Alzheimer Disease
    Early Onset
    Alzheimer Disease
    Late Onset
    Alzheimer Disease 9
    Alzheimer Disease 4
    Alzheimer Disease 7
    Alzheimer Disease 17
    Alzheimer's Dementia Late Onset
    Alzheimer Disease 5
    Alzheimer Disease 6
    Alzheimer Disease 8
    Alzheimer Disease 10
    Alzheimer Disease 11
    Alzheimer Disease 12
    Alzheimer Disease 13
    Alzheimer Disease 14
    Alzheimer Disease 15
    Alzheimer Disease 16
    Alzheimer Disease 18
    Alzheimer Disease 19
    Dementia
    Dementia Alzheimers
    Dementia
    Mild
    Dementia of Alzheimer Type
    Dementia Moderate
    Dementia Senile
    Mild Cognitive Impairment
    Mild Dementia
    MCI
    Cognitive Impairment
    Cognitive Decline
    Cognitive Impairment
    Mild

NCT05637801

Cognito Therapeutics, Inc.

22 June 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.